Howland E. Crosswell

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Ann S. LaCasce, R. Gregory Bociek, Ahmed Sawas et al. · Blood · 2018 · 253 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer

Stephen Shuford, Christine Wilhelm, Melissa Rayner et al. · Scientific Reports · 2019 · 64 citations · Full text

Medicine, Gynecology, Oncology +17

Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma

Ann S. LaCasce, Gregory Bociek, Ahmed Sawas et al. · Blood · 2015 · 61 citations

Medicine, Oncology, Pharmacotherapy +10

A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies

Shashikant Srivastava, Jotam G. Pasipanodya, Geetha Ramachandran et al. · EBioMedicine · 2016 · 47 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of <i>HOXA9</i> and <i>MEIS1</i> Expression

Alison R. Walker, John C. Byrd, James S. Blachly et al. · Clinical Cancer Research · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +13